Company intelligence / Profile preview

Electromed

New Prague, Minnesota, United Statessmartvest.com ↗

Ownership: Public · ELMD
Employees: ~174
Development stage: Commercial

Overview

Electromed’s flagship product, the SmartVest Airway Clearance System, is a commercially available high frequency chest wall oscillation device designed to improve airway clearance and pulmonary function in patients with chronic respiratory conditions. The company reports strong growth and profitability driven by direct-to-patient distribution and increasing awareness of HFCWO therapy benefits[2][4][5].

Therapeutic areas: PulmonologyNeurology
Modalities: Device
Industry: Therapeutic Medical Devices

Financials

Market cap: $227.8M
Total revenue: $19.4M
Enterprise value: $207.5M

Beyond the preview

Go deeper on Electromed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Electromed.

Explore the full profile